The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer
about
AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studiesThree-dimensional cell culture systems and their applications in drug discovery and cell-based biosensorsTargeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future PerspectivesInfluence of Matrices on 3D-Cultured Prostate Cancer Cells' Drug Response and Expression of Drug-Action Associated ProteinsIdentification of Gastric Cancer Biomarkers Using 1H Nuclear Magnetic Resonance SpectrometryTherapeutically blocking Interleukin-11 Receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours.Three-dimensional cell culture: a breakthrough in vivo.Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma.Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures.Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma.Modeling Ewing sarcoma tumors in vitro with 3D scaffoldsCulture phases, cytotoxicity and protein expressions of agarose hydrogel induced Sp2/0, A549, MCF-7 cell line 3D culturesLiquid-based three-dimensional tumor models for cancer research and drug discovery.Resveratrol and acetyl-resveratrol modulate activity of VEGF and IL-8 in ovarian cancer cell aggregates via attenuation of the NF-κB protein.hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma.Proton NMR characterization of intact primary and metastatic melanoma cells in 2D & 3D cultures.Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells.Towards personalized medicine: chemosensitivity assays of patient lung cancer cell spheroids in a perfused microfluidic platform.Differences of SiHa (human cancer of cervix) and BMG-1 (brain glioma) cell lines as 2D and 3D cultures.Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance.Comparative Analysis of 3D Bladder Tumor Spheroids Obtained by Forced Floating and Hanging Drop Methods for Drug Screening.Advanced cell culture techniques for cancer drug discovery.A tag-less method for direct isolation of human umbilical vein endothelial cells by gravitational field-flow fractionation.3D spheroids' sensitivity to electric field pulses depends on their size.Evaluation of photodynamic therapy efficiency using an in vitro three-dimensional microfluidic breast cancer tissue model.Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.Assessing multiparametric drug response in tissue engineered tumor microenvironment models.Emerging Roles of Electrospun Nanofibers in Cancer Research.Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction.Spheroids Formation on Non-Adhesive Surfaces by Liquid Overlay Technique: Considerations and Practical Approaches.Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.Imaging of Intracellular pH in Tumor Spheroids Using Genetically Encoded Sensor SypHer2.A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models.The Electrorotation as a Tool to Monitor the Dielectric Properties of Spheroid During the Permeabilization.Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure
P2860
Q21089821-483CADD8-12EB-41F0-8E1F-86E1C54D8DA4Q27023623-CAC88F42-F70B-4137-9600-5F54710AAC56Q28066286-F390EB35-2C10-47AF-829A-F0E4A418EB3FQ28552225-6B02CB5D-0854-475E-A312-CCE3034B67F1Q28553966-154181FD-2A6A-4486-BDEC-E524CDF61D70Q33618450-E63B60DF-E998-4FE5-A87C-27BA80B4A08CQ35381163-7567EBAC-E8AC-4DB5-84CE-F059F251C481Q35657004-072178AC-B17B-40D4-B8DF-60FBD93A5D44Q35985227-0E334774-2126-492F-9AF0-B7E563730067Q35989688-7BE49CE7-82F4-4359-8990-46274CD7DD0AQ36782138-6B260F37-363C-462F-88E2-8FB78D4157B2Q36840429-F2A0AB55-0E6E-4CA2-ADB5-2B70FC124153Q37107139-082C942F-C101-4C59-AED3-8798B83A71F7Q37466290-6F3CFCD2-0A8F-476D-B343-16A952A281FFQ37492231-1501AA98-9A4E-41A0-9EC2-9520028060B7Q37704991-359C282A-F112-4539-A7DF-4F5872C9548EQ38756515-93758EF3-07D7-4CF2-AADB-B51A5B3CFA21Q38862433-99B60054-8B28-42E7-A318-B4620D7FC77CQ39121018-51CDE770-A8C6-409B-B59A-90538BFCC99CQ41009718-E3A1911A-0A7A-489C-B827-E1269EAA5656Q41525387-BFAD11B9-630E-4F60-9287-1896525BD258Q41827250-56A5D209-1277-44C9-9AE6-03BB62C1AFBFQ43755582-EEE34DA8-1E2D-4169-A619-38A8E6939780Q45765368-9E4EDB2C-FED9-4BFB-ABD6-AED3B50602F2Q46809811-21D1B4AE-CCE7-45E6-9B7B-C379523AEC2FQ47164952-62498729-EEB6-4DF5-ADC1-B45D82A648DBQ47233873-F2FE9568-5D4D-4777-80BD-EDAE701250BBQ47279115-4E306A21-E8CE-4CD3-9F04-290FB9E2199DQ47311101-32E3302A-8058-4507-916B-1D96BB44F124Q47804995-BEE9E2BA-4A4F-466C-9ACB-9C84E0878C3FQ48147436-FB08A5E8-5E80-4F60-A7BC-B6EEF0E98E1EQ48373900-C28CF206-F755-4916-9774-C0E799E03C05Q50052675-BFF1ABB0-1A40-4909-B7A8-901D69A7447AQ50100692-64BC5A64-BC59-41F7-A054-A5158B613765Q51110603-7FC31AD1-6CBE-43FB-B992-75F24334E4DBQ51489238-BF3F7820-A34A-456E-A6EF-743820D26812Q58697190-A7A70BE0-4D38-4C03-8BFD-D1D1CEB1EC41
P2860
The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The resistance of intracellula ...... n 3D and 2D endometrial cancer
@ast
The resistance of intracellula ...... n 3D and 2D endometrial cancer
@en
type
label
The resistance of intracellula ...... n 3D and 2D endometrial cancer
@ast
The resistance of intracellula ...... n 3D and 2D endometrial cancer
@en
prefLabel
The resistance of intracellula ...... n 3D and 2D endometrial cancer
@ast
The resistance of intracellula ...... n 3D and 2D endometrial cancer
@en
P2860
P356
P1476
The resistance of intracellula ...... n 3D and 2D endometrial cancer
@en
P2093
John J Evans
Kenny Chitcholtan
P2860
P2888
P356
10.1186/1479-5876-10-38
P577
2012-03-06T00:00:00Z
P5875
P6179
1013795845